Sonic Healthcare – Buy

SHL:ASX is under Algo Engine buy conditions and is a current holding in our ASX model portfolio.

FY22 revenue is likely to be around $7.6bn on EBITDA of $1.7bn. EPS will be 30 – 40% up on FY20, which will support a forward yield of 3.5%.

You’re not a member!  Trial today

Ready to elevate your investing?

Join Investor Signals today and start your journey to better, more disciplined returns.